Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04099277 · OUTCOME

Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151

A Study of LY3435151 in Participants With Solid Tumors · Source last updated 2021-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
GEOMETRIC_MEAN
Unit
microgram per milliliter (µg/mL)
Interval / dispersion
Geometric Coefficient of Variation
Time frame
Cycle 1 Day 1 (C1D1) (Predose, 1, 3 hour (hr), C1D2 (24 hr), C1D4 (72hr), C1D8 (168hr), C1D15 (336hr)

What was measured

Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151.

Analysis population: All randomized participants who received at least one dose of study drug and had evaluable PK data.

Groups in this outcome

10 mg LY3435151

Participants received 10 mg dose of LY3435151 via intravenous (IV) as an IV push or IV bolus infusion.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
10 mg LY34351512

Reported measurements

Source class 1
Values in microgram per milliliter (µg/mL) · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
10 mg LY3435151NANANot reportedNot reported2.07, 7.16 (Individual values reported as there were only two participants)
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        2.07, 7.16 (Individual values reported as there were only two participants)
        group Id
        OG000
        spread
        NA
        value
        NA
denoms
  1. counts
    1. group Id
      OG000
      value
      2
    units
    Participants
description
Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151.
dispersion Type
Geometric Coefficient of Variation
groups
  1. description
    Participants received 10 mg dose of LY3435151 via intravenous (IV) as an IV push or IV bolus infusion.
    id
    OG000
    title
    10 mg LY3435151
param Type
GEOMETRIC_MEAN
population Description
All randomized participants who received at least one dose of study drug and had evaluable PK data.
reporting Status
POSTED
time Frame
Cycle 1 Day 1 (C1D1) (Predose, 1, 3 hour (hr), C1D2 (24 hr), C1D4 (72hr), C1D8 (168hr), C1D15 (336hr)
title
Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151
type
SECONDARY
unit Of Measure
microgram per milliliter (µg/mL)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice